Provided by Tiger Trade Technology Pte. Ltd.

DELCATH SYSTEMS INC

17.03
-0.1100-0.64%
Volume:131.60K
Turnover:2.24M
Market Cap:590.92M
PE:1.16K
High:17.14
Open:17.11
Low:16.84
Close:17.14
52wk High:17.42
52wk Low:8.12
Shares:34.70M
Float Shares:28.59M
Volume Ratio:0.54
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0147
EPS(LYR):0.0700
ROE:0.47%
ROA:-0.89%
PB:4.88
PE(LYR):243.29

Loading ...

Delcath Systems Q1 Gross Profit USD 21.258 Million

THOMSON REUTERS
·
May 07

Delcath Systems Q1 EPS USD -0.03

THOMSON REUTERS
·
May 07

Delcath reports new ESMO data on melphalan hepatic perfusion in metastatic breast cancer

Reuters
·
May 07

Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 05

Canaccord Genuity Reaffirms Their Buy Rating on Delcath Systems (DCTH)

TIPRANKS
·
May 05

Delcath Systems to host first-quarter earnings call

Reuters
·
Apr 23

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 22

Delcath announces Chemosat Hepatic system recommended for liver treatment

TIPRANKS
·
Apr 06

Delcath Systems, Inc. Announces Inclusion of Chemosat Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the Esmo–Euracan Clinical Practice Guidelines for Uveal Melanoma

THOMSON REUTERS
·
Apr 06

Delcath Systems announces annual shareholder meeting in proxy statement

Reuters
·
Apr 02

Delcath Systems to present HEPZATO experience at Society of Interventional Radiology meeting

Reuters
·
Apr 01

Delcath Systems CFO Sandra Pennell Acquires Common Shares

Reuters
·
Mar 07

Delcath Systems CEO Gerard J Michel Acquires Common Shares

Reuters
·
Mar 04

Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), SOPHiA GENETICS (SOPH) and InfuSystem Holdings (INFU)

TIPRANKS
·
Mar 03

BRIEF-Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology

Reuters
·
Mar 03

Delcath Systems Publishes CHOPIN Phase 2 Trial Results in The Lancet Oncology

Reuters
·
Mar 03

Delcath Systems Announces Publication of Chopin Clinical Trial Results in the Lancet Oncology

THOMSON REUTERS
·
Mar 03

Delcath Systems Inc : Btig Cuts Target Price to $19 From $23

THOMSON REUTERS
·
Feb 27

Delcath Systems Is Maintained at Buy by BTIG

Dow Jones
·
Feb 27

Delcath Systems price target lowered to $27 from $29 at Clear Street

TIPRANKS
·
Feb 27